Berthiaume and Yarmush Receive NIH Grant to Develop New Nanoparticle Therapy

Professors Francois Berthiaume and Martin Yarmush have received a 2-year $442,327 NIH R21 grant. The goal of the project is to develop new nanoparticle-based delivery systems for various growth factors and bioactive peptides that can be incorporated into conventional modalities currently used in clinical wound applications. This work will lead to a new generation of topical therapies for improved skin wound healing.